Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Orthobiologics Devices And Equipment Market be in 2030 compared with 2026?
The orthobiologics devices and equipment market has shown substantial growth over recent years. It is anticipated to expand from $5.99 billion in 2025 to $6.36 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The expansion seen in the past can be attributed to several factors, including an increase in musculoskeletal disorders, the widespread occurrence of sports injuries, the rise in orthopedic surgeries, the growing adoption of PRP therapies, and the clinical effectiveness of bone grafts.
The orthobiologics devices and equipment market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $8.64 billion, exhibiting a compound annual growth rate (CAGR) of 8.0%. Several factors contribute to this forecasted growth, including an increase in the aging population, innovations in regenerative medicine, a rising demand for minimally invasive treatments, broader reimbursement policies, and advancements in biomaterial technology. Key trends expected during this period involve the increasing adoption of regenerative therapies, a surge in sports injury treatments, greater utilization of stem cell-based products, a preference for non-surgical orthopedic interventions, and the proliferation of orthopedic clinics.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2568&type=smp
What Drivers Are Guiding Growth Patterns In The Orthobiologics Devices And Equipment Market?
The growing occurrence of orthopedic conditions is anticipated to boost the expansion of the orthobiologics devices and equipment market in the future. These disorders are defined as ailments impacting the musculoskeletal system, comprising bones, joints, muscles, ligaments, tendons, and nerves. The need for orthopedic treatments is rising because of the world’s aging population, given that older people are more susceptible to musculoskeletal issues like osteoarthritis, osteoporosis, and fractures. Orthobiologics devices and equipment assist in managing orthopedic disorders by fostering natural tissue regeneration and more effectively helping to recover bone and joint function. They enhance treatment results by improving healing efficiency and shortening patient recovery periods. For example, a survey study conducted in August 2023 by the Institute for Health Metrics and Evaluation, a US-based public health research institute, revealed that 15% of people aged 30 and above had osteoarthritis in 2023, with projections indicating that approximately 1 billion individuals will be affected by 2050. Consequently, the rising incidence of orthopedic disorders is propelling the expansion of the orthobiologics devices and equipment market.
Which Segments Are Driving Activity In The Orthobiologics Devices And Equipment Market?
The orthobiologics devices and equipment market covered in this report is segmented –
1) By Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics
2) By Application: Osteoarthritis And Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery
3) By End Use: Hospitals, Orthopedic Clinics, Other End Users
Subsegments:
1) By Demineralized Bone Matrix: Injectable Demineralized Bone Matrix, Paste And Putty Forms, Demineralized Bone Matrix Scaffolds
2) By Synthetic Bone Substitutes: Calcium Phosphate Ceramics, Bioactive Glasses, Polymers And Composites
3) By Stem Cell Therapy: Adipose-Derived Stem Cell Products, Bone Marrow-Derived Stem Cell Products, Umbilical Cord Blood-Derived Stem Cell Products
4) By Plasma-Rich Protein: Platelet-Rich Plasma (PRP) Products, Platelet-Rich Fibrin (PRF) Products
5) By Viscosupplementation: Hyaluronic Acid Injections, Combination Viscosupplementation Products
6) By Bone Morphogenetic Protein (BMP): Recombinant Bone Morphogenetic Proteins, BMP Delivery Systems
7) By Synthetic Orthobiologics: Growth Factor-Enhanced Products, Biodegradable Scaffolds With Bioactive Agents, Other Synthetic Formulations
Which Trends Are Influencing The Development Of The Orthobiologics Devices And Equipment Market?
Leading companies in the orthobiologics devices and equipment market are concentrating on the development of advanced regenerative technologies, such as synthetic bone fusion gels, to enhance surgical outcomes, improve healing, and decrease complications. Synthetic bone fusion gels represent sophisticated biomaterial formulations that serve as a scaffold and a delivery system for growth factors, thereby stimulating bone growth in spinal fusion and orthopedic procedures. For instance, in January 2024, Renovos Biologics Ltd., a UK-based biomaterial company and investee of Biocomposites, was awarded Food and Drug Administration (FDA) Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, Renovite BMP-2. This is a novel, injectable, and moldable gel specifically formulated to contain and keep bone morphogenetic protein-2 (BMP-2) precisely at the surgical site. The aim of this technology is to encourage effective bone healing while mitigating the risk of ectopic bone formation and other soft-tissue complications often associated with older carrier systems, facilitating a more regulated and efficient fusion process.
Which Major Industry Participants Are Leading The Orthobiologics Devices And Equipment Market Growth?
Major companies operating in the orthobiologics devices and equipment market are BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp.
Access The Complete Report For Deeper Market Insights:
Which Geographic Areas Are Emerging As Strong Markets For The Orthobiologics Devices And Equipment Market?
North America was the largest region in the global Ortho biologics devices and equipment market in 2025. Western Europe was the second-largest region in the orthobiologics devices and equipment market report. The regions covered in the orthobiologics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Orthobiologics Devices And Equipment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2568&type=smp
Browse Through More Reports Similar to the Global Orthobiologics Devices And Equipment Market 2026, By The Business Research Company
Orthopedic Braces And Support Devices And Equipment Global Market Report 2026
Orthopedic Accessories Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/orthopedic-accessories-global-market-report
Orthopedic Biomaterials Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/orthopedic-biomaterials-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company